Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Group C meningococcal conjugate vaccine shown safe and immunogenic in phase II

June 25, 1998

Immunosuppressive, antiinflammatory and antitumor rapamycin derivatives

June 23, 1998

University of Pittsburgh awarded grant for dendritic cell research

June 22, 1998

DTaP-IPV nears approval in several European countries

June 22, 1998

SangStat receives U.S. patent covering multiple ciclosporin formulations

June 19, 1998

Vaccine carrier offered for licensing by biosyn Arzneimittel

June 19, 1998

Novel rapamycin derivatives patented by AHP

June 11, 1998

U.S., European patents on Idec's gp39 program to be issued

June 4, 1998

Advances in ChimeriVax vaccines presented by OraVax

June 2, 1998

Cel-Sci receives SBIR grant for herpes simplex vaccine

June 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...